Short answer · Medically reviewed summary · Last updated: 2026-04-07
Floating-Harbor syndrome is a rare genetic disorder primarily characterized by short stature, delayed bone age, and specific facial features, and it is most commonly known by this eponymous name. While it has occasionally been referred to as Pelletier-Leisti syndrome in historical medical literature, Floating-Harbor syndrome is the universally accepted clinical term used in modern medical databases and international classification systems. Why does Floating-Harbor syndrome have different names? The naming of Floating-Harbor syndrome reflects the history of medical discovery.
Floating-Harbor syndrome is a rare genetic disorder primarily characterized by short stature, delayed bone age, and specific facial features, and it is most commonly known by this eponymous name. While it has occasionally been referred to as Pelletier-Leisti syndrome in historical medical literature, Floating-Harbor syndrome is the universally accepted clinical term used in modern medical databases and international classification systems.
The naming of Floating-Harbor syndrome reflects the history of medical discovery. The condition was first described in 1973 by Drs. R.M. Pelletier and J.T. Leisti, and for a period, it was referred to as Pelletier-Leisti syndrome. However, the name Floating-Harbor syndrome was later adopted to honor the two hospitals where the initial cases were identified: Floating Hospital for Children in Boston and Harbor General Hospital in Los Angeles. In rare disease research, eponymous names based on discovery locations or original authors are common, but the move toward standardizing Floating-Harbor syndrome ensures that clinicians and researchers globally use consistent terminology to avoid confusion in patient records and literature searches.
In formal medical classification systems, Floating-Harbor syndrome is recognized through specific identifiers that help ensure accurate tracking and research. These codes are essential for clinicians when coding for billing, research, or patient registry purposes:
While Floating-Harbor syndrome is the standard, you may encounter a few variations or older descriptors in medical archives. It is important to note that these are not distinct conditions, but rather historical synonyms for the same clinical presentation:
For all medical communication, clinical documentation, and patient advocacy, Floating-Harbor syndrome is the preferred and widely recognized term. Using this name ensures that your healthcare providers can access the most current research, clinical trials, and support communities, such as the 11 individuals currently connected through DiseaseMaps.org. When discussing the condition with specialists or insurance providers, using the official name and the OMIM identifier (#136140) can help prevent administrative delays and ensure that your medical team is referencing the correct genetic profile associated with the SRCAP gene mutation.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.